News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Suda Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025
Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
Health & Biotech
Check Up: From Moderna’s effective jabs to Patrys’ brain cancer breakthrough
Health & Biotech
Suda Pharma pops 44pc on cap raise; Acrux and other biotechs whet investor appetites
News
ASX Small Cap Lunch Wrap: Who’s digesting the news today?
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Is Suda back on track after securing first TGA approval?
Health & Biotech
World-renown cancer institute to investigate Kazia Therapeutics drug
News
10 at 10: These ASX stocks are vying for silverware this morning
Stockhead TV
StockTalk: Drug delivery tech offers patients, investors massive upside
Health & Biotech
Drug delivery technology: How it works, and the ASX companies with plans to capitalise
Health & Biotech
Weed week: Cannabis researchers are still split on matters of the heart
Health & Biotech
Check up: Maybe next week will be better?
Experts
